902 KAR 55:020. Schedule II substances.

 

      RELATES TO: KRS 218A.010-218A.030, 218A.060-218A.070, 21 C.F.R. 1308.12

      STATUTORY AUTHORITY: KRS 218A.060

      NECESSITY, FUNCTION, AND CONFORMITY: KRS 218A.020 authorizes the Cabinet for Health Services to add, delete, or reschedule substances enumerated in KRS Chapter 218A. This administrative regulation designates Schedule II controlled substances.

 

      Section 1. Depressants. (1) Except as provided in subsection (2) of this section, the Cabinet for Health Services designates as Schedule II controlled substances, in addition to those specified by KRS 218A.070, a material, compound, mixture, or preparation which contains a quantity of the following substances:

      (a) Amobarbital;

      (b) Glutethimide;

      (c) Pentobarbital; and

      (d) Secobarbital.

      (2) A suppository dosage form containing amobarbital, secobarbital, or pentobarbital or any of their salts, which has been approved by the United States Food and Drug Administration for marketing only as a suppository, shall be in Schedule III.

 

      Section 2. Immediate Precursors. The Cabinet for Health Services designates as Schedule II controlled substances, in addition to those specified by KRS 218A.070, a material, compound, mixture, or preparation which contains a quantity of the following substances:

      (1) Immediate precursors to amphetamine and methamphetamine and substances:

      (a) Phenyl-2-propanone;

      (b) P2P;

      (c) Benzyl methyl ketone; and

      (d) Methyl benzyl ketone; and

      (2) Immediate precursors to phencyclidine:

      (a) 1-phenylcyclohexylamine; and

      (b) 1-piperidinocyclohexanecarbonitrile, also known as PCC.

 

      Section 3. Hallucinogenic Substances. The Cabinet for Health Services designates as Schedule II controlled substances, in addition to those specified by KRS 218A.070, a material, compound, mixture, or preparation which contains a quantity of the following substances: Nabilone, also known as (plus or minus) - trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo{b,d}pyran-9-one.

 

      Section 4. Opium and Derivatives. The Cabinet for Health Services designates as Schedule II controlled substances, in addition to those specified by KRS 218A.070, opium and opiates, and a salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and their respective salts, but including the following:

      (1) Raw opium;

      (2) Opium extracts;

      (3) Opium fluid;

      (4) Powdered opium;

      (5) Granulated opium;

      (6) Tincture of opium;

      (7) Codeine;

      (8) Ethylmorphine;

      (9) Etorphine hydrochloride;

      (10) Hydrocodone;

      (11) Hydromorphone;

      (12) Metopon;

      (13) Morphine;

      (14) Oxycodone;

      (15) Oxymorphone; and

      (16) Thebaine.

 

      Section 5. Opiates. The Cabinet for Health Services designates as Schedule II controlled substances, in addition to those specified by KRS 218A.070, the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters, and ethers if the existence of such isomers, esters, ethers, or salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:

      (1) Alfentanil;

      (2) Bulk dextropropoxyphene, in nondosage forms;

      (3) Carfentanil;

      (4) Levo-alphacetylmethadol (LAAM);

      (5) Remifentanil; and

      (6) Sufentanil. (Recodified from 901 KAR 1:020, 4-14-82; Am. 11 Ky.R. 1675; eff. 6-4-85; 12 Ky.R. 1176; eff. 2-4-86; 13 Ky.R. 1945; eff. 6-9-87; 17 Ky.R. 3048; eff. 6-19-91; 20 Ky.R. 859; eff. 12-6-93; 26 Ky.R. 1237; 1561; eff. 2-1-2000.)